Updated:
Cornucopian Capital
Cornucopian Capital uses long-term capital to build and support results-focused, high integrity companies that use scientific knowledge and accessible...
Cornucopian Capital
Cornucopian Capital uses long-term capital to build and support results-focused, high integrity companies that use scientific knowledge and accessible technologies to help everyone attain improved healthspan, enhanced performance, and extended longevity. The firm invests in early VC stages from pre-Seed and Seed to Series A and B+ with initial check sizes ranging from $250,000 to $5M. It focuses on Medicine 3.0 companies spanning personalized care, consumer bioactives, therapeutics, biomeasurement technologies, and ecosystem infrastructure.
General information
Firm type
Private Equity
Year founded
2020
Location
Region
North America
Country
United States
City
Davis
Corporate office
Davis, United States
Principals
Aryeh Ganz
Managing Partner
Jinny Choi
General Partner
Rachelle Peluso
Operating Partner
William Zhang
Senior Associate
Matei Vaduva
Research Analyst
Avi Rosenbaum
Venture Partner
Giovanni Battistini
Venture Partner
Erich Veitenheimer III
Advisor
Justin Siegel
PhD, Advisor
Phil Johnston
Advisor
Joe Wang
Advisor
Tricia Ulricksen
Talent Partner
Sector focus
Frequently asked questions
What stages does Cornucopian Capital target?
Records list coverage of early stage, seed, start-up, growth, and general venture.
Where is Cornucopian Capital based?
The firm is recorded in Davis, United States.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on private equity firms?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: